瑞普生物 (300119.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务摘要(单季度)(瑞普生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年第四季度2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
单季度财务指标:
 单季度销售毛利率(%) 47.0049.0053.0051.0050.0047.0048.0049.00
 单季度销售净利率(%) 33.0017.0019.0020.0019.0018.0014.0020.00
 单季度净资产收益率ROE(%) 4.002.002.002.003.002.002.002.00
 单季度总资产净利率ROA(%) 3.002.002.001.002.002.001.001.00
单季度财务摘要:
 单季度营业总收入(元) 661,797,277.00593,068,520.00551,315,774.00442,780,482.00607,489,442.00568,423,568.00517,530,813.00390,806,577.00
 单季度营业总成本(元) 559,935,083.00490,508,424.00462,076,485.00361,812,574.00516,829,104.00459,410,507.00442,124,558.00313,567,271.00
 单季度营业收入(元) 661,797,277.00593,068,520.00551,315,774.00442,780,482.00607,489,442.00568,423,568.00517,530,813.00390,806,577.00
 单季度营业利润(元) 238,511,828.00110,828,140.00117,356,013.0098,534,255.00131,971,693.00115,893,777.0084,112,711.0084,660,248.00
 单季度利润总额(元) 240,594,522.00110,979,183.00116,923,017.0098,183,332.00128,877,539.00115,760,230.0083,657,368.0085,516,257.00
 单季度净利润(元) 216,115,761.00101,427,051.00105,971,087.0087,502,826.00117,753,655.00102,428,119.0073,999,378.0079,588,705.00
 单季度归属母公司股东的净利润(元) 179,244,071.0095,426,859.0097,447,672.0080,823,461.00113,677,869.0093,188,240.0067,626,659.0072,205,917.00
 单季度经营活动产生的现金流量(元) 181,228,987.0060,208,062.00107,547,108.0029,212,172.00188,568,602.00137,029,909.00118,426,724.00-54,538,255.00
 单季度投资活动产生的现金流量(元) -320,341,696.00155,593,137.00-46,574,525.0050,348,475.00-292,262,040.00-415,814,903.00-45,177,968.00-491,477,076.00
 单季度筹资活动产生的现金流量(元) 78,234,055.00-115,512,724.00-100,896,687.00-134,285,632.00-140,338,696.0044,377,541.0068,794,468.00-21,178,986.00
 单季度现金及现金等价物净增加(元) -60,869,209.00100,300,442.00-39,904,654.00-54,701,597.00-244,083,337.00-234,341,085.00142,072,080.00-567,194,317.00

前瞻产业研究院